Eletriptan hydrobromide
Drug ingredientCAS 177834-92-3
This chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
US productionNot reported
Top sourceNo public record
This chemical is not on EPA’s Toxic Substances Control Act inventory, the list behind EPA’s production survey.
Why supply is unknownWhere It Comes From
EPA and Census publish no US supply data for this chemical.
18 FDA-registered drug labelers
Advanced Rx of Tennessee, LLC
Aurobindo Pharma Limited
Bryant Ranch Prepack
Camber Pharmaceuticals, Inc.
Direct_Rx
F.I.S. FABBRICA ITALIANA SINTETICI SPA
Hetero Drugs Limited
Matrix Pharmacorp Private Limited
Mylan Pharmaceuticals Inc.
Pfizer Italia S.r.l.
Quality Care Products, LLC
ROERIG
Teva API India Private Ltd
Teva Pharmaceuticals USA, Inc.
Viatris Specialty LLC
Yung Shin Pharmaceutical Ind. Co., Ltd.
Zydus Lifesciences Limited
Zydus Pharmaceuticals USA Inc.
Why It Matters
Sectors
Health
Downstream Uses
Appears in 3 drug and cosmetic product listings (FDA).
- •Eletriptan hydrobromide
- •Relpax
- •Eletriptan HBR
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No FDA shortage records
Chemical Identity
CAS177834-92-3
PubChem CID656631
DTXSIDDTXSID001016113
FormulaC22H27BrN2O2S
Mol. Weight463.4 g/mol
SMILESCN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4.Br
Data Sources
- PubChem · compound 656631Retrieved 2026-04-07
- FDA National Drug Code directoryRetrieved 2026-04-25
- FDA National Drug Code directoryRetrieved 2026-04-07
Brief citations
Eletriptan hydrobromide (CAS 177834-92-3) https://chemicalindependence.com/chemical/177834-92-3/ PubChem: 656631. Retrieved 2026-04-07. https://pubchem.ncbi.nlm.nih.gov/compound/656631 FDA National Drug Code directory: CAS 177834-92-3. Retrieved 2026-04-25. https://open.fda.gov/data/ndc/ FDA National Drug Code directory: bulk match. Retrieved 2026-04-07. https://open.fda.gov/data/ndc/